Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Link between high-affinity adenosine concentrative nucleoside transporter-2 (CNT2) and energy metabolism in intestinal and liver parenchymal cells.

Huber-Ruano I, Pinilla-Macua I, Torres G, Casado FJ, Pastor-Anglada M.

J Cell Physiol. 2010 Nov;225(2):620-30. doi: 10.1002/jcp.22254.

PMID:
20506327
2.

Hypoxia and P1 receptor activation regulate the high-affinity concentrative adenosine transporter CNT2 in differentiated neuronal PC12 cells.

Medina-Pulido L, Molina-Arcas M, Justicia C, Soriano E, Burgaya F, Planas AM, Pastor-Anglada M.

Biochem J. 2013 Sep 15;454(3):437-45. doi: 10.1042/BJ20130231.

PMID:
23819782
3.

Molecular determinants of specificity for synthetic nucleoside analogs in the concentrative nucleoside transporter, CNT2.

Owen RP, Badagnani I, Giacomini KM.

J Biol Chem. 2006 Sep 8;281(36):26675-82. Epub 2006 Jul 13.

4.

TGF-beta transcriptionally activates the gene encoding the high-affinity adenosine transporter CNT2 in rat liver parenchymal cells.

Valdés R, Fernández-Veledo S, Aymerich I, Casado FJ, Pastor-Anglada M.

Cell Mol Life Sci. 2006 Nov;63(21):2527-37.

PMID:
17013559
5.

Bile acids alter the subcellular localization of CNT2 (concentrative nucleoside cotransporter) and increase CNT2-related transport activity in liver parenchymal cells.

Fernández-Veledo S, Huber-Ruano I, Aymerich I, Duflot S, Casado FJ, Pastor-Anglada M.

Biochem J. 2006 Apr 15;395(2):337-44. Erratum in: Biochem J. 2014 Jun 15;460(3):473.

6.

The concentrative nucleoside transporter family (SLC28): new roles beyond salvage?

Aymerich I, Duflot S, Fernández-Veledo S, Guillén-Gómez E, Huber-Ruano I, Casado FJ, Pastor-Anglada M.

Biochem Soc Trans. 2005 Feb;33(Pt 1):216-9.

PMID:
15667311
8.

NKCC2 surface expression in mammalian cells: down-regulation by novel interaction with aldolase B.

Benziane B, Demaretz S, Defontaine N, Zaarour N, Cheval L, Bourgeois S, Klein C, Froissart M, Blanchard A, Paillard M, Gamba G, Houillier P, Laghmani K.

J Biol Chem. 2007 Nov 16;282(46):33817-30. Epub 2007 Sep 11.

9.

ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.

Duflot S, Riera B, Fernández-Veledo S, Casadó V, Norman RI, Casado FJ, Lluís C, Franco R, Pastor-Anglada M.

Mol Cell Biol. 2004 Apr;24(7):2710-9.

10.

A new level of regulation in gluconeogenesis: metabolic state modulates the intracellular localization of aldolase B and its interaction with liver fructose-1,6-bisphosphatase.

Droppelmann CA, Sáez DE, Asenjo JL, Yáñez AJ, García-Rocha M, Concha II, Grez M, Guinovart JJ, Slebe JC.

Biochem J. 2015 Dec 1;472(2):225-37. doi: 10.1042/BJ20150269. Epub 2015 Sep 28.

PMID:
26417114
11.
12.

Cloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2.

Li JY, Boado RJ, Pardridge WM.

J Cereb Blood Flow Metab. 2001 Aug;21(8):929-36.

PMID:
11487728
13.

Extracellular adenosine activates AMP-dependent protein kinase (AMPK).

Aymerich I, Foufelle F, Ferré P, Casado FJ, Pastor-Anglada M.

J Cell Sci. 2006 Apr 15;119(Pt 8):1612-21. Epub 2006 Mar 28.

14.

Nucleoside transporter expression and function in cultured mouse astrocytes.

Peng L, Huang R, Yu AC, Fung KY, Rathbone MP, Hertz L.

Glia. 2005 Oct;52(1):25-35.

PMID:
15892125
15.

Cytidine is a novel substrate for wild-type concentrative nucleoside transporter 2.

Nagai K, Nagasawa K, Koma M, Hotta A, Fujimoto S.

Biochem Biophys Res Commun. 2006 Aug 25;347(2):439-43. Epub 2006 Jun 27.

PMID:
16828706
16.

Distribution of CNT2 and ENT1 transcripts in rat brain: selective decrease of CNT2 mRNA in the cerebral cortex of sleep-deprived rats.

Guillén-Gómez E, Calbet M, Casado J, de Lecea L, Soriano E, Pastor-Anglada M, Burgaya F.

J Neurochem. 2004 Aug;90(4):883-93.

17.

Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2.

Owen RP, Gray JH, Taylor TR, Carlson EJ, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, Giacomini KM.

Pharmacogenet Genomics. 2005 Feb;15(2):83-90.

PMID:
15861032
18.

Hypouricemic effects of novel concentrative nucleoside transporter 2 inhibitors through suppressing intestinal absorption of purine nucleosides.

Hiratochi M, Tatani K, Shimizu K, Kuramochi Y, Kikuchi N, Kamada N, Itoh F, Isaji M.

Eur J Pharmacol. 2012 Sep 5;690(1-3):183-91. doi: 10.1016/j.ejphar.2012.06.015. Epub 2012 Jun 16.

PMID:
22709993
19.

Role of the transporter regulator protein (RS1) in the modulation of concentrative nucleoside transporters (CNTs) in epithelia.

Errasti-Murugarren E, Fernández-Calotti P, Veyhl-Wichmann M, Diepold M, Pinilla-Macua I, Pérez-Torras S, Kipp H, Koepsell H, Pastor-Anglada M.

Mol Pharmacol. 2012 Jul;82(1):59-67. doi: 10.1124/mol.111.076992. Epub 2012 Apr 9.

20.

Developmental regulation of the concentrative nucleoside transporters CNT1 and CNT2 in rat liver.

del Santo B, Tarafa G, Felipe A, Casado FJ, Pastor-Anglada M.

J Hepatol. 2001 Jun;34(6):873-80.

PMID:
11451171

Supplemental Content

Support Center